Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.verified

ATOS

Price:

$2.46

Market Cap:

$21.18M

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen. This compound, an active metabolite derived from tamoxifen, is currently undergoing Phase II clinical trials for both the treatment and prevention of breast cancer. Beyond this, Atossa is also advancing immunotherapy and chimeric antigen receptor (CAR) therapy programs. Established in 2008, the company adopted its current name, Atossa Therapeutics, Inc.,...[Read more]

Industry

Biotechnology

IPO Date

2012-11-08

Stock Exchange

NASDAQ

Ticker

ATOS

The ROE as of June 2026 (TTM) for Atossa Therapeutics, Inc. (ATOS) is -84.91%

According to Atossa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -84.91%. This represents a change of 271.99% compared to the average of -22.83% of the last 4 quarters.

Atossa Therapeutics, Inc. (ATOS) Historical ROE (quarterly & annually)

How has ATOS ROE performed in the past?

The mean historical ROE of Atossa Therapeutics, Inc. over the last ten years is -84.38%. The current -84.91% ROE has changed 0.63% with respect to the historical average. Over the past ten years (40 quarters), ATOS's ROE was at its highest in in the September 2016 quarter at 3.78%. The ROE was at its lowest in in the March 2017 quarter at -111.46%.

Quarterly (TTM)
Annual

Average

-84.38%

Median

-76.99%

Minimum

-205.64%

Maximum

-14.92%

Atossa Therapeutics, Inc. (ATOS) ROE by Quarter and Year

Discovering the peaks and valleys of Atossa Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 147.62%

Maximum Annual ROE = -14.92%

Minimum Annual Increase = -77.27%

Minimum Annual ROE = -205.64%

Quarterly (TTM)
Annual
YearROEChange
2025-88.35%147.62%
2024-35.68%7.91%
2023-33.06%44.67%
2022-22.85%53.21%
2021-14.92%-77.27%
2020-65.62%-49.92%
2019-131.04%1.17%
2018-129.53%10.65%
2017-117.06%-43.07%
2016-205.64%-51.18%

Atossa Therapeutics, Inc. (ATOS) Average ROE

How has ATOS ROE performed in the past?

The current ROE of Atossa Therapeutics, Inc. (ATOS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-52.37%

5-year avg

-38.97%

10-year avg

-84.38%

Atossa Therapeutics, Inc. (ATOS) ROE vs. Peers

How is ATOS’s ROE compared to its peers?

Atossa Therapeutics, Inc.’s ROE is less than Oncolytics Biotech Inc. (5.21%), less than Tevogen Bio Holdings Inc. (241.39%), greater than Greenwich LifeSciences, Inc. (-814.48%), greater than Instil Bio, Inc. (-39.76%), greater than Immix Biopharma, Inc. (-73.23%), greater than Whitehawk Therapeutics Inc (-79.63%), less than Clene Inc. (233.93%), less than Surrozen, Inc. (309.79%), greater than Cognition Therapeutics, Inc. (-72.68%), greater than Coya Therapeutics, Inc. (-57.26%),

Build a custom stock screener for Atossa Therapeutics, Inc. (ATOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atossa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atossa Therapeutics, Inc. (ATOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atossa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Atossa Therapeutics, Inc.'s ROE?

How is the ROE calculated for Atossa Therapeutics, Inc. (ATOS)?

What is the highest ROE for Atossa Therapeutics, Inc. (ATOS)?

What is the 3-year average ROE for Atossa Therapeutics, Inc. (ATOS)?

What is the 5-year average ROE for Atossa Therapeutics, Inc. (ATOS)?

How does the current ROE for Atossa Therapeutics, Inc. (ATOS) compare to its historical average?